|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-6-30
|
|
pubmed:abstractText |
To determine whether C-terminal provasopressin (copeptin) explains the prognostic importance of insulin growth factor binding protein-1 (IGFBP-1) in patients with myocardial infarction and type 2 diabetes.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-12090978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-15728645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-16269513,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-16399017,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-17133186,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-17420344,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-17563335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-18291667,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-18362294,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-18777208,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-19349193,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-19366852,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-6083690,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-7521354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413521-9402139
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1935-5548
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1604-6
|
|
pubmed:dateRevised |
2011-8-1
|
|
pubmed:meshHeading |
pubmed-meshheading:20413521-Aged,
pubmed-meshheading:20413521-Death, Sudden, Cardiac,
pubmed-meshheading:20413521-Diabetes Mellitus, Type 2,
pubmed-meshheading:20413521-Female,
pubmed-meshheading:20413521-Follow-Up Studies,
pubmed-meshheading:20413521-Glycopeptides,
pubmed-meshheading:20413521-Humans,
pubmed-meshheading:20413521-Insulin-Like Growth Factor Binding Protein 1,
pubmed-meshheading:20413521-Male,
pubmed-meshheading:20413521-Middle Aged,
pubmed-meshheading:20413521-Myocardial Infarction,
pubmed-meshheading:20413521-Predictive Value of Tests,
pubmed-meshheading:20413521-Prognathism,
pubmed-meshheading:20413521-Proportional Hazards Models,
pubmed-meshheading:20413521-Randomized Controlled Trials as Topic,
pubmed-meshheading:20413521-Risk Factors,
pubmed-meshheading:20413521-Stroke
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.
|
|
pubmed:affiliation |
Department of Medicine, Karolinska Institutet, Stockholm, Sweden. linda.mellbin@karolinska.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
